KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Acquisitions (2016 - 2025)

Resmed (RMD) has disclosed Acquisitions for 16 consecutive years, with $522000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Acquisitions changed N/A year-over-year to $522000.0, compared with a TTM value of $139.1 million through Dec 2025, up 527.91%, and an annual FY2025 reading of $139.2 million, up 4.33% over the prior year.
  • Acquisitions was $522000.0 for Q3 2025 at Resmed, down from $138.6 million in the prior quarter.
  • Across five years, Acquisitions topped out at $992.1 million in Q4 2022 and bottomed at $522000.0 in Q3 2025.
  • Average Acquisitions over 5 years is $98.0 million, with a median of $16.0 million recorded in 2021.
  • The sharpest move saw Acquisitions surged 2662.43% in 2022, then crashed 99.24% in 2023.
  • Year by year, Acquisitions stood at $35.9 million in 2021, then soared by 2662.43% to $992.1 million in 2022, then plummeted by 99.24% to $7.5 million in 2023, then crashed by 91.07% to $670000.0 in 2024, then dropped by 22.09% to $522000.0 in 2025.
  • Business Quant data shows Acquisitions for RMD at $522000.0 in Q3 2025, $138.6 million in Q2 2025, and $670000.0 in Q4 2024.